Liudahl SM, Coussens LM (2018) B cells as biomarkers: predicting immune checkpoint therapy adverse events. J Clin Invest. 2018 Feb 1;128(2):577-579. - Stand Up To Cancer

Blog

Posted October 7, 2019

Liudahl SM, Coussens LM (2018) B cells as biomarkers: predicting immune checkpoint therapy adverse events. J Clin Invest. 2018 Feb 1;128(2):577-579.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.